Cargando…

SARS-CoV-2 infection and the antiviral innate immune response

Detalles Bibliográficos
Autores principales:	Yang, Hui, Lyu, Yingying, Hou, Fajian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798998/ https://www.ncbi.nlm.nih.gov/pubmed/33377937 http://dx.doi.org/10.1093/jmcb/mjaa071

Ejemplares similares

Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022)

NOD2-dependent BCG-induced trained immunity: A way to regulate innate responses to SARS-CoV2?
por: Wannigama, Dhammika Leshan, et al.
Publicado: (2020)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

An autoinhibitory mechanism modulates MAVS activity in antiviral innate immune response
por: Shi, Yuheng, et al.
Publicado: (2015)

Does pollen exposure influence innate immunity to SARS-CoV-2 in allergy or asthma?
por: Hajighasemi, Saeideh, et al.
Publicado: (2023)

The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
por: Gu, Wenjing, et al.
Publicado: (2022)

Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection
por: Sauerwald, Natalie, et al.
Publicado: (2022)

Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges
por: Wu, Tangchun
Publicado: (2020)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
por: Burtscher, Johannes, et al.
Publicado: (2020)

WDR77 inhibits prion-like aggregation of MAVS to limit antiviral innate immune response
por: Li, Jiaxin, et al.
Publicado: (2023)

SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy
por: Li, Xingyu, et al.
Publicado: (2021)

Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
por: Netea, Mihai G., et al.
Publicado: (2020)

An Update on Innate Immune Responses during SARS-CoV-2 Infection
por: Zhang, Yu, et al.
Publicado: (2021)

The Endoplasmic Reticulum ATP13A1 is Essential for MAVS‐Mediated Antiviral Innate Immunity
por: Zhang, Rui, et al.
Publicado: (2022)

Structural basis for the prion-like MAVS filaments in antiviral innate immunity
por: Xu, Hui, et al.
Publicado: (2014)

Author Correction: WDR77 inhibits prion-like aggregation of MAVS to limit antiviral innate immune response
por: Li, Jiaxin, et al.
Publicado: (2023)

Cross-reactive memory T cells and herd immunity to SARS-CoV-2
por: Lipsitch, Marc, et al.
Publicado: (2020)

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021)

RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection
por: Marx, Samira, et al.
Publicado: (2022)

Diminished antiviral innate immune gene expression in the placenta following a maternal SARS-CoV-2 infection
por: Coler, Brahm, et al.
Publicado: (2023)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

Phase Separation: The Robust Modulator of Innate Antiviral Signaling and SARS-CoV-2 Infection
por: Zheng, Yi, et al.
Publicado: (2023)

Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection
por: Balkhi, Mumtaz Y.
Publicado: (2021)

Considering innate immune responses in SARS-CoV-2 infection and COVID-19
por: Diamond, Michael S., et al.
Publicado: (2022)

Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection
por: Islamuddin, Mohammad, et al.
Publicado: (2022)

Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
por: Zhu, Qiugang, et al.
Publicado: (2022)

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals
por: Saksena, Nitin K., et al.
Publicado: (2023)

Role of the early secretory pathway in SARS-CoV-2 infection
por: Sicari, Daria, et al.
Publicado: (2020)

SARS-CoV-2 infections in children: Understanding diverse outcomes
por: Brodin, Petter
Publicado: (2022)

Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
por: Sajini, Abdulrahim A., et al.
Publicado: (2021)

Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses
por: Mihaescu, Grigore, et al.
Publicado: (2021)

Author Correction: SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy
por: Li, Xingyu, et al.
Publicado: (2023)

The Many Faces of Innate Immunity in SARS-CoV-2 Infection
por: Hanan, Nicholas, et al.
Publicado: (2021)

Innate immunity to SARS-CoV-2 infection: a review
por: Silva, Marcos Jessé Abrahão, et al.
Publicado: (2022)

Correction: Structural basis for the prion-like MAVS filaments in antiviral innate immunity
por: Xu, Hui, et al.
Publicado: (2015)

MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation
por: Zhou, Peipei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d778u39hv9442mfute2qlofdev